Ketamine as a Novel Antidepressant: From Synapse to Behavior

被引:127
作者
Murrough, J. W. [1 ,2 ,3 ]
机构
[1] Mt Sinai Sch Med, Dept Psychiat, Mood & Anxiety Disorders Program, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA
[3] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA
基金
美国国家卫生研究院;
关键词
D-ASPARTATE ANTAGONIST; NMDA RECEPTOR BLOCKADE; TREATMENT-RESISTANT DEPRESSION; CEREBRAL-BLOOD-FLOW; PREFRONTAL CORTEX; TERM OUTCOMES; HUMANS; METABOLISM; GLUTAMATE; DISORDER;
D O I
10.1038/clpt.2011.244
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent reports of a rapid antidepressant effect of the glutamate N-methyl-D-aspartate (NMDA) receptor antagonist ketamine, even in treatment-resistant populations, have spurred translational therapeutic and neuroscience research aimed at elucidating ketamine's mechanism of action. This article provides a concise overview of research findings that pertain to the effects of low-dose ketamine at the cellular, neurocircuitry, and behavioral levels and describes an integrated model of the action of ketamine in the treatment of depression.
引用
收藏
页码:303 / 309
页数:7
相关论文
共 41 条
[1]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[2]   NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses [J].
Autry, Anita E. ;
Adachi, Megunai ;
Nosyreva, Elena ;
Na, Elisa S. ;
Los, Maarten F. ;
Cheng, Peng-fei ;
Kavalali, Ege T. ;
Monteggia, Lisa M. .
NATURE, 2011, 475 (7354) :91-U109
[3]   Antidepressant effects of ketamine in depressed patients [J].
Berman, RM ;
Cappiello, A ;
Anand, A ;
Oren, DA ;
Heninger, GR ;
Charney, DS ;
Krystal, JH .
BIOLOGICAL PSYCHIATRY, 2000, 47 (04) :351-354
[4]   Antidepressant Effect of Optogenetic Stimulation of the Medial Prefrontal Cortex [J].
Covington, Herbert E., III ;
Lobo, Mary Kay ;
Maze, Ian ;
Vialou, Vincent ;
Hyman, James M. ;
Zaman, Samir ;
LaPlant, Quincey ;
Mouzon, Ezekiel ;
Ghose, Subroto ;
Tamminga, Carol A. ;
Neve, Rachael L. ;
Deisseroth, Karl ;
Nestler, Eric J. .
JOURNAL OF NEUROSCIENCE, 2010, 30 (48) :16082-16090
[5]   Glutamate and the neural basis of the subjective effects of ketamine [J].
Deakin, J. F. William ;
Lees, Jane ;
Mckie, Shane ;
Hallak, Jaime E. C. ;
Williams, Steve R. ;
Dursun, Serdar M. .
ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (02) :154-164
[6]   Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder [J].
DiazGranados, Nancy ;
Ibrahim, Lobna A. ;
Brutsche, Nancy E. ;
Ameli, Rezvan ;
Henter, Ioline D. ;
Luckenbaugh, David A. ;
Machado-Vieira, Rodrigo ;
Zarate, Carlos A., Jr. .
JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (12) :1605-1611
[7]   A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression [J].
Diazgranados, Nancy ;
Ibrahim, Lobna ;
Brutsche, Nancy E. ;
Newberg, Andrew ;
Kronstein, Phillip ;
Khalife, Sami ;
Kammerer, William A. ;
Quezado, Zenaide ;
Luckenbaugh, David A. ;
Salvadore, Giacomo ;
Machado-Vieira, Rodrigo ;
Manji, Husseini K. ;
Zarate, Carlos A., Jr. .
ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (08) :793-802
[8]   A neurotrophic model for stress-related mood disorders [J].
Duman, Ronald S. ;
Monteggia, Lisa M. .
BIOLOGICAL PSYCHIATRY, 2006, 59 (12) :1116-1127
[9]   Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus [J].
Garcia, Leda S. B. ;
Comim, Clarissa M. ;
Valvassori, Samira S. ;
Reus, Gislaine Z. ;
Barbosa, Luciana M. ;
Andreazza, Ana Cristina ;
Stertz, Laura ;
Fries, Gabriel R. ;
Gavioli, Elaine Cristina ;
Kapczinski, Flavio ;
Quevedo, Joao .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (01) :140-144
[10]   Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats [J].
Garcia, Leda S. B. ;
Comim, Clarissa M. ;
Valvassori, Samira S. ;
Reus, Gislaine Z. ;
Stertz, Laura ;
Kapczinski, Flavio ;
Gavioli, Elaine C. ;
Quevedo, Joao .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (03) :450-455